Acquisitions (Acquisition-Related Costs) (Details) (USD $) In Thousands	3 Months Ended	6 Months Ended
Jun. 30, 2011	Jun. 30, 2011
Acquisition-related costs	$ 1,000	$ 10,928
Taligen Therapeutics, Inc [Member]
Separately-identifiable employee costs		6,597
Professional fees	41	2,729
Changes in the fair value of contingent consideration	666	750
Acquisition-related costs	707	10,076
Orphatec Pharmaceuticals GmbH [Member]
Professional fees	214	721
Changes in the fair value of contingent consideration	79	131
Acquisition-related costs	$ 293	$ 852

This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 141R
-Paragraph 59
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 25
-Paragraph 23
-URI http://asc.fasb.org/extlink&oid=6909708&loc=d3e1043-128460

Name:	us-gaap_BusinessCombinationAcquisitionRelatedCosts
Namespace Prefix:	us-gaap
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration